XNAS · LNTH
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Lantheus Holdings, Inc

Lantheus Holdings, Inc

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$100.91
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
LNTH
Lantheus Holdings, Inc
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

60/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LNTH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LNTH catalysts
About Lantheus Holdings, Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
2015
Employees
1K
Country
US

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$100.91
Last session
Day high
$100.91
Last session
Day low
$100.91
Last session
Previous close
$100.91
52W high
$110.94
-9.04% from high
52W low
$50.11
84% of range
Market cap
$6.6B
Beta
0.49
Shares out
65.3M
Avg volume
1.6M
VWAP
$100.91
Last session
Price history computed in-house
1W
+0.23%
1M
-6.21%
3M
+5.02%
1Y
+80.29%
YTD
+51.63%
SMA 50 $103.99 · below
SMA 200 $80.98 · above
52W position 84%

LNTH overview

Loading financial statements
Loading LNTH Form 4 filings
Public disclosures

Congress activity in LNTH

Federal contracts

LNTH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LNTH in this window.
Lobbying spend

LNTH lobbying filings, year to date.

Registered lobbying filings matched to Lantheus Holdings, Inc.

$662.0K
Refresh interval: 12hSource: LDA disclosure filings
Filing
$332.0K
LANTHEUS HOLDINGS INC.

LANTHEUS HOLDINGS, INC.

Jul 20, 2026
Filing
$330.0K
LANTHEUS HOLDINGS INC.

LANTHEUS HOLDINGS, INC.

Apr 20, 2026
Loading news for LNTH
Analyst ratings
Sovereign unlock shows live analyst consensus for LNTH.
Options
Sovereign unlock shows live options positioning for LNTH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.